» Articles » PMID: 33193709

Hamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning

Overview
Journal Front Genet
Date 2020 Nov 16
PMID 33193709
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxic/ischemic preconditioning (HPC/IPC) is an innate neuroprotective mechanism in which a number of endogenous molecules are known to be involved. Tuberous sclerosis complex 1 (TSC1), also known as hamartin, is thought to be one such molecule. It is also known that hamartin is involved as a target in the rapamycin (mTOR) signaling pathway, which functions to integrate a variety of environmental triggers in order to exert control over cellular metabolism and homeostasis. Understanding the role of hamartin in ischemic/hypoxic neuroprotection will provide a novel target for the treatment of hypoxic-ischemic disease. Therefore, the proposed molecular mechanisms of this neuroprotective role and its preconditions are reviewed in this paper, with emphases on the mTOR pathway and the relationship between the expression of hamartin and DNA methylation.

Citing Articles

Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate.

Wang S, Ma R, Gao C, Tian Y, Hu R, Zhang H Stem Cell Res Ther. 2025; 16(1):38.

PMID: 39901197 PMC: 11792405. DOI: 10.1186/s13287-025-04170-3.


Hypoxia preconditioning increases Notch1 activity by regulating DNA methylation in vitro and in vivo.

Chang Z, Liu Q, Fan P, Xu W, Xie Y, Gong K Mol Biol Rep. 2024; 51(1):507.

PMID: 38622406 DOI: 10.1007/s11033-024-09308-9.


Hypoxic Preconditioning Modulates BDNF and Its Signaling through DNA Methylation to Promote Learning and Memory in Mice.

Zhang S, Fu W, Jia X, Bade R, Liu X, Xie Y ACS Chem Neurosci. 2023; 14(12):2320-2332.

PMID: 37289948 PMC: 10289091. DOI: 10.1021/acschemneuro.3c00069.


Possible Involvement of DNA Methylation in TSC1 Gene Expression in Neuroprotection Induced by Hypoxic Preconditioning.

Qi R, Xie Y, Zhang X, Jiang S, Liu X, Xie W Oxid Med Cell Longev. 2022; 2022:9306097.

PMID: 36120601 PMC: 9481362. DOI: 10.1155/2022/9306097.


The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury.

Wang L, Li S, Stone S, Liu N, Gong K, Ren C Biomolecules. 2022; 12(1).

PMID: 35053294 PMC: 8773505. DOI: 10.3390/biom12010146.

References
1.
Cid C, Garcia-Bonilla L, Camafeita E, Burda J, Salinas M, Alcazar A . Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance. Proteomics. 2007; 7(17):3207-18. DOI: 10.1002/pmic.200700214. View

2.
Fazzari M, Greally J . Epigenomics: beyond CpG islands. Nat Rev Genet. 2004; 5(6):446-55. DOI: 10.1038/nrg1349. View

3.
Shao G, Lu G . Hypoxic preconditioning in an autohypoxic animal model. Neurosci Bull. 2012; 28(3):316-20. PMC: 5560319. DOI: 10.1007/s12264-012-1222-x. View

4.
Chakraborty S, Azeem Mohiyuddin S, Gopinath K, Kumar A . Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer. 2008; 8:163. PMC: 2430211. DOI: 10.1186/1471-2407-8-163. View

5.
Browne G, Proud C . A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol. 2004; 24(7):2986-97. PMC: 371112. DOI: 10.1128/MCB.24.7.2986-2997.2004. View